Aditxt Commences Participant Enrollment for Mitomic Endometriosis Test Research
Aditxt announced that its subsidiary, Pearsanta, has begun enrollment in their prospective clinical study evaluating the Mitomic Endometriosis Test, a novel blood-based diagnostic designed to aid in the early detection of endometriosis.
